← Leaderboards
George I Papakostas
Massachusetts General Hospital
$2,720,018
Attributed
$2,720,018
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $573K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,720,018 · 2
By mechanism
R01$1,839,486 · 1
K23$880,532 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Amy Karol Walker$9,451,083
- Nabeel Bardeesy$18,920,034
- Ahmed A Tawakol$9,912,063
- Roy H Perlis$23,588,460
- Bradley T Hyman$51,936,441
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchDesignDouble-Blind MethodSelective Serotonin Reuptake InhibitorEnrollmentDropsProgramsPlacebosResistanceSafetyMassachusettsResponseFundingMajor Depressive DisorderAntidepressive AgentsDepressive SymptomsDoseAdverse EffectsMental DepressionAnalogAtypical AntipsychoticPainDouble-Blind Placebo Controlled TrialAmbulatory Care Facilities
Grant awards (10)
1/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$359,618
R01 · FY2012 · MH · contact PI
1/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$359,618
R01 · FY2011 · MH · contact PI
1/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$363,250
R01 · FY2010 · MH · contact PI
1/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$362,125
R01 · FY2009 · MH · contact PI
1/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$394,875
R01 · FY2008 · MH · contact PI
S-Adenosyl Methionine(SAMe)Augmentation of SSRIs in MDD$178,166
K23 · FY2008 · MH · contact PI
S-Adenosyl Methionine(SAMe)Augmentation of SSRIs in MDD$178,166
K23 · FY2007 · MH · contact PI
S-Adenosyl Methionine(SAMe)Augmentation of SSRIs in MDD$178,166
K23 · FY2006 · MH · contact PI
S-Adenosyl Methionine(SAMe)Augmentation of SSRIs in MDD$174,780
K23 · FY2005 · MH
S-Adenosyl Methionine(SAMe)Augmentation of SSRIs in MDD$171,254
K23 · FY2004 · MH